In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against the other Jim Cramer stocks. Jim Cramer recently highlighted a promising start to earnings ...

McKesson Corporation (NYSE:MCK) shareholders might be concerned after seeing the share price drop 14% in the last quarter. But that doesn't change the fact that the returns over the last five ...